Gilead Sciences' Next Chapter - In A Coronavirus Based World, Gilead Sciences' Antiviral Strength Is KeySeeking Alpha • 02/06/20
Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/05/20
Here's a Better Reason to Buy Gilead Sciences Stock Than a Possible Coronavirus TreatmentThe Motley Fool • 02/04/20